Hypothyroidism induces growth retardation and decreases the circulating concentrations of GH and IGF-I. To study the effects of thyroid hormone on GHR and IGF-I expression, we measured rat liver and kidney GHR and IGF-I mRNI\ levels by solution hybridization RNase protection assay. Three to six 21 day-old castrated male rats per group were given either pure water or 0.0259 methimazole in their drinking water. and subcutaneous pellet containing either placebo or thyroxine (T4) 2.5 mg. After 13 days. the animals were sacrificed. Serum free T4 and IGF-I levels were determined by RIA. Liver and kidney GHR and IGF-I.WA were measured by solution hybridization using specific antisense riboprobes. Protected bands corresponding to GHR and IGF-I MU4A were quantified using a Phosphorlmager.
EFFECTS OF THYROID H O M N E ON GROWl'H HORHONE RECEPTOR (GHR
Hypothyroidism induces growth retardation and decreases the circulating concentrations of GH and IGF-I. To study the effects of thyroid hormone on GHR and IGF-I expression, we measured rat liver and kidney GHR and IGF-I mRNI\ levels by solution hybridization RNase protection assay. Three to six 21 day-old castrated male rats per group were given either pure water or 0.0259 methimazole in their drinking water. and subcutaneous pellet containing either placebo or thyroxine (T4) 2.5 mg. After 13 days. the animals were sacrificed. Serum free T4 and IGF-I levels were determined by RIA. Liver and kidney GHR and IGF-I.WA were measured by solution hybridization using specific antisense riboprobes. Protected bands corresponding to GHR and IGF-I MU4A were quantified using a Phosphorlmager.
LIVER KIDlJCI width Free T4 IGF-I GHR mRNA GHR mRNA GHR nRNA (mm) (ng/dl) (ng/ml) (9) (9) (9) Hypothyroid rats grew slower than controls. IGF-I mRNA levels were reduced in liver but not in kidney, and were normalized after thyroxine treatment. GH receptor W A levels were increased in liver of rats receiving methimazole. and were decreased in the kidney of hypothyroid rats. These findings suggest that the reduction in IGF-I synthesis observed in hypothyroid rats is not mediated thouah a decrease in liver GH receptor expression. Cord blood neonatal screening for congenital hypothyroidism was carried out from October 1991 to December 1992 in Maternidad Rambn Sarda. It has been determined by TSH RIA. A total of 7365 dried blood samples from newborns were tested. Two hypothyroids (incidence 1:3682)and 2 transient hypothyroids(incidence 1: 3682) and 6 false positives (with TSH between 30 and 50 uU/ml) were detected.The recall rate was 0.14'aversus 0.043that is the rate we have in our screening after 48 hs of life. In order to decrease the recall rate in cord blood 76 samples from newborns were tested in parallel with RIA (DPC) and IRMA (ICN). The interassay coefficients of variation of RIA and IRMA were 20% and 5%. with a detection limit of 25 uU/ml and 2.5 uU/ml respectively. Distribution of TSH concentration (uU/ml) determined by RIA and IRMA was a follows: RIA results were lower than IRMA(pc 0.001)(Wilcoxon's test). No correlation was found between the 2 mothods (r:0.13 Spearman rank). We suggest that IRMA neonatal assay represents a true alternative to RIA and has better sensitivity and specificity for cord blood samples allowing to decrease false positive results. Hypoglycemia in children carries high risk of CNS lesions. Early recognition and adequate therapy are mandatory. We report our experience with ffiH and PD in 3 children with severe HH due to ICD. Case 1, a 13 months-old white boy with severe hypoglicemic sindrome since the age of 11 months. presented neuroglycopenic signs. marked muscular hypotonia and 2 episodes of loss of conscience. Full description of the case has already been published (Acta Pediatr Suppl 388:121-5.1993) .Case 2, a 70 days white girl. had a seizure at 50 days of life; physical findings were unremarkable. Patient 3 was a white boy with one day age, who was in hypoglycemic coma from 12 to 17 hours of age.HH was documented in each patient. GH.cortisol,T3.T4,TSH, blood chemistry and immageologic studies were normal. EEG was deeply altered in case 3. Case 1, although having persistent neuroglycopenic symptoms had normal EEG. Patients received ffiH (0.16-0.4 IU/Kg) and PD(10 mg/m2) on a daily basis. Patient 3 required the highest dose of GH but recovered neither consciousness nor normal glycemia. He died at the age of 47 days during status epilepticus. Cases 1 and 2 have been on therapy for 37 and 12 months respectively with normalization of blood glucose; however serum insulin has kept persistently high. Patient 1 has had normalization of neurological disturbances. Surgery Celiac disease is a chronic illness that produces malabsortion. which can induce important undernutrition and alterations in calcium metabolism. We were interested in bone mineralization (BM) in celiac patients, with adequate compliance of dietetic treatment. at least during the last year. In 14 female celiacs an evaluation was carried out of the characteristics at birth, at the time of the diagnosis and at the start of this study. BM was measured in the whole body. spine and hip (trocanter. Ward' triangle and femoral neck) with a double isotopic densitometer (Norland). Results were compared with those obtained in 66 nonnal school age females of the same age. It was found that celiacs had less birth weight and lenght. less weight/age adequation and less body weight than controls. % of adequation of BM of whole body was significantly less than controls either in total bone mass as well as in bone Turner Syndrome (TS) is associated with multiple malformations and skeletal abnormalities, including an alteration in bone mineralization (BM), present since infancy. We were interested in evaluating the current state of BM in TS patients. 30 patients (6 8/12 -17 3/12 years) with cariotype certification of TS were studied. Antropometric characteristic were evaluated at birth and at the time of the study. In all of them. BH of whole body, spine and hip (femoral neck, trocanter and Ward's triangle) was performed using adual photon isotopic densitometer (Norland). They were compared with 93 nonnal girls of same ages. TS patients had lower weight and height at birth, a lower H/A and higher W/H adequation than controls. with significant difference. The percentage of adequations of BM of whole body in total bone mass (TBM) and bone mineral density (BUD) was significatively lower than in controls (63.0 2 12.8 vs. 100.0 2 18.6 and 87.3 2 10.4 vs 1EM.1 2 10.8 respectively). At spine level there were significative differences in TBM. BMC and BND (72.2 2 15.2 vs 180.0 +_ 19.8; 81.1 2 15.3 vs 100.0 +_ 16.2 and 89.5 +_ 16.2 vs 1W1.0 +_ 15.7 respectively). In hip (neck, trocanter and Ward's triangle) the same high significative differences were observed. Stratificating the patients according to age. those under 10 6/12 years have a significantly lower BM, being these girls a risk group of severe osteoporosis and fractures in adult life.
12
MEDIAN CONFIDENCE INTERVAL 99"b. MINIMUM V. MAXIMUM
BIOSYNTHETIC HUMAN GROWTH HORHONE (ffiH) AND PREDNISONE (PD) COMBI-NED THERAPY FOR HYPERINSULINWC HYPCGLICEKIX (HH) DUE TO ISLET CELL DISMATURITY (ICD

